Biotechnology Institute Thurgau at the University of Konstanz
Publications Dr. Christoph Ratswohl
- Ratswohl C, Vázquez García C, Ahmad AUW, Gonschior H, Lebedin M, Silvis CE, Spatt L, Gerhard C, Lehmann M, Sander LE, Kurth F, Olsson S, de la Rosa K. 2023. A design strategy to generate a SARS-CoV-2 RBD vaccine that abrogates ACE2 binding and improves neutralizing antibody responses. Eur J Immunol Jul 12:e2350408. doi: 10.1002/eji.202350408. Online ahead of print.
- Lebedin M, García CV, Spatt L, Ratswohl C, Thibeault C, Ostendorf L, Alexander T, Paul F, Sander LE, Kurth F, de la Rosa K. 2023. Discriminating promiscuous from target-specific autoantibodies in COVID-19. Eur J Immunol May;53(5):e2250210. doi: 10.1002/eji.202250210. Epub 2023 Apr 3.
- Lebedin M, Foglierini M, Khorkova S, Vázquez García C, Ratswohl C, Davydov AN, Turchaninova MA, Daubenberger C, Chudakov DM, Lanzavecchia A, de la Rosa K. 2022. Different classes of genomic inserts contribute to human antibody diversity. Proc Natl Acad Sci U S A Sep 6;119(36):e2205470119. doi: 10.1073/pnas.2205470119. Epub 2022 Aug 29.
- Meyer-Arndt L, Braun J, Fauchere F, Vanshylla K, Loyal L, Henze L, Kruse B, Dingeldey M, Jürchott K, Mangold M, Maraj A, Braginets A, Böttcher C, Nitsche A, de la Rosa K, Ratswohl C, Sawitzki B, Holenya P, Reimer U, Sander LE, Klein F, Paul F, Bellmann-Strobl J, Thiel A, Giesecke-Thiel C. 2022. SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod. J Neurol Neurosurg Psychiatry Sep;93(9):960-971. doi: 10.1136/jnnp-2022-329395. Epub 2022 Jul 14.
- Catakovic K, Gassner FJ, Ratswohl C, Zaborsky N, Rebhandl S, Schubert M, Steiner M, Gutjahr JC, Pleyer L, Egle A, Hartmann TN, Greil R, Geisberger R. 2017. TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia. Oncoimmunology Sep 21;7(1):e1371399. doi: 10.1080/2162402X.2017.1371399. eCollection 2017.
